Coiled Therapeutics (AIM:COIL, OTCQB:COTXF), the clinical-stage oncology company developing precision medicines for hard-to-treat cancers, said chairman Sotirios Stergiopoulos will present at the Proactive One2One Investor Forum in London on 24 June.
The event will take place at The Chesterfield Mayfair and begin at 6pm. A recording of the presentation will be made available on the company’s website. Investors can register to attend through the event organiser’s online registration portal.